REQUEST A DEMO
Total
USD $0.00
Search more companies

Amgen Biotechnologia Sp. z o.o. (Poland)

Main Activities: Wholesale Trade Agents and Brokers
Secondary Activities: Administrative Management and General Management Consulting Services | Educational Support Services
Full name: Amgen Biotechnologia Sp. z o.o. Profile Updated: February 14, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Amgen Biotechnologia Sp. z o.o is a biotech company that uses genetic engineering to discover, develop, and deliver drugs for severe diseases such as cancer, kidney failure, osteoporosis, and rheumatoid arthritis. They focus on developing drugs and supporting educational development programs. Amgen aims to improve treatment results and the quality of life for patients through the production and supply of innovative medicines of human origin.

Headquarters
Ul. Pulawska 145
Warsaw; Mazowieckie; Postal Code: 02-715

Contact Details: Purchase the Amgen Biotechnologia Sp. z o.o. report to view the information.

Website: http://www.amgen.pl

Basic Information
Total Employees:
Purchase the Amgen Biotechnologia Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Amgen Biotechnologia Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Amgen Biotechnologia Sp. z o.o. report to view the information.
Incorporation Date:
September 26, 2011
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
99%
Company Performance
Financial values in the chart are available after Amgen Biotechnologia Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
0.22%
Total operating revenue
0.22%
Operating Profit/Loss (EBIT)
-6.54%
EBITDA
-19.2%
Net Profit/Loss for the Period
6.14%
Total Assets
30.62%
Total Equity
24.2%
Operating Profit Margin (ROS)
-0.48%
Net Profit Margin
0.34%
Return on Equity (ROE)
-3.31%
Debt/Equity
-0.53%
Quick Ratio
-0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?